Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates

Cigdem Alkan, Eduardo Jurado-Cobena, Tetsuro Ikegami

Research output: Contribution to journalReview articlepeer-review

Abstract

Rift Valley fever (RVF) is a zoonotic viral disease transmitted by mosquitoes and causes abortion storms, fetal malformations, and newborn animal deaths in livestock ruminants. In humans, RVF can manifest as hemorrhagic fever, encephalitis, or retinitis. Outbreaks of RVF have been occurring in Africa since the early 20th century and continue to pose a threat to both humans and animals in various regions such as Africa, Madagascar, the Comoros, Saudi Arabia, and Yemen. The development of RVF vaccines is crucial in preventing mortality and morbidity and reducing the spread of the virus. While several veterinary vaccines have been licensed in endemic countries, there are currently no licensed RVF vaccines for human use. This review provides an overview of the existing RVF vaccines, as well as potential candidates for future studies on RVF vaccine development, including next-generation vaccines that show promise in combating the disease in both humans and animals.

Original languageEnglish (US)
Article number171
Journalnpj Vaccines
Volume8
Issue number1
DOIs
StatePublished - Dec 2023

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates'. Together they form a unique fingerprint.

Cite this